View More Recent Stories
-
Korro Bio (KRRO) Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates
-
BMO Capital Reiterates Outperform Rating on Korro Bio Inc. (KRRO)
-
Korro Bio (KRRO) Misses Q2 EPS by 243c
-
Piper Sandler Reiterates Overweight Rating on Korro Bio Inc. (KRRO)
-
William Blair Starts Korro Bio Inc. (KRRO) at Outperform
-
Korro Bio Inc. (KRRO) PT Lowered to $95 at RBC Capital
-
RBC's biotech survey shows investors more bearish vs. last time
-
Korro Bio (KRRO) Announces Resignation of Chief Scientific Officer

